Perspective Therapeutics (CATX) FCF Margin Growth (3y) (2013 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 22,034.00 |
| Sep 30, 2023 | -48,795.00 |
| Jun 30, 2023 | -48,763.00 |
| Mar 31, 2023 | -51,084.00 |
| Sep 30, 2022 | -7,548.00 |
| Jun 30, 2022 | -12,156.00 |
| Mar 31, 2022 | 2,637.00 |
| Dec 31, 2021 | 16,260.00 |
| Sep 30, 2021 | 2,711.00 |
| Mar 31, 2021 | 4,635.00 |
| Dec 31, 2020 | 7,064.00 |
| Sep 30, 2020 | 12,270.00 |
| Jun 30, 2020 | 6,892.00 |
| Mar 31, 2020 | 8,859.00 |
| Dec 31, 2019 | 10,779.00 |
| Sep 30, 2019 | 10,632.00 |
| Jun 30, 2019 | 8,774.00 |
| Mar 31, 2019 | 569.00 |
| Dec 31, 2018 | 648.00 |
| Sep 30, 2018 | -2,224.00 |
| Jun 30, 2018 | -4,999.00 |
| Mar 31, 2018 | 2,671.00 |
| Jun 30, 2017 | -278.00 |
| Mar 31, 2017 | -7,569.00 |
| Dec 31, 2016 | -9,144.00 |
| Sep 30, 2016 | -5,360.00 |
| Jun 30, 2016 | -8,036.00 |
| Mar 31, 2016 | -2,140.00 |
| Dec 31, 2015 | -1,193.00 |
| Sep 30, 2015 | 60.00 |
| Jun 30, 2015 | 280.00 |
| Mar 31, 2015 | -3,842.00 |
| Jun 30, 2014 | -5,329.00 |
| Mar 31, 2014 | -231.00 |
| Dec 31, 2013 | -2,458.00 |
| Sep 30, 2013 | -3,677.00 |